Internal Medicine Alert - October 30, 2008

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Executive Editor
Stephen A. Brunton, MD
Clinical Professor
University of California, Irvine

Associate Editors
Barbara A. Phillips, MD, MSPH
Professor of Medicine, University of Kentucky
Director, Sleep Disorders Center
Samaritan Hospital
Lexington

Malcolm Robinson, MD, FACP, FACG, AGAF
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine
Oklahoma City

Allan J. Wilke, MD
Residency Program Director
Associate Professor of Family Medicine
University of Alabama at Birmingham School of Medicine
?Huntsville Regional Medical Campus, Huntsville

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

New Hope for COPD?
CT Colonographic Screening: Does the Technique Merit Widespread Adoption?
Intensive Glucose Lowering: Too Much of a Good Thing?
Clinical Briefs by Louis Kuritzky, MD

Objectives:

describe new findings in differential diagnosis and treatment of various diseases
describe controversies, advantages, and disadvantages of those advances
describe cost-effective treatment regimens
describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Eli Lilly, Endo, Novartis, and Novo Nordisk. Peer reviewer Gerald Roberts, MD, reports no financial relationship to this field of study. Associate editors Barbara A. Phillips, MD, MSPH, Malcolm Robinson, MD, FACP, FACG, AGAF, and Allan J. Wilke, MD report no financial relationship to this field of study. Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.